Introduction
Patients with heart failure have a high morbidity and mortality despite the recent advancement of heart failure treatment. The number of patients is markedly increasing, and five-year mortality still remains approximately 50% [1] . The condition of heart failure is defined as the decompensation of the hemodynamics with insufficient blood demand to peripheral tissues, not only due to low cardiac output caused by reduced myocardial contraction, but also due to the impairment of myocardial stiffness, increased vessel resistance, or systemic fluid unbalance. Even if cardiac function is preserved at rest, the impairment of myocardial relaxation in left ventricular hypertrophy [2] , or the reduced myocardial functional reserve in myocardial contraction and relaxation at physical or pharmacological stress [3, 4] could cause heart failure. Accordingly, it is important to evaluate in detail the myocardial property of the failing heart with reduced cardiac functional reserve.
The pathogenesis of the failing heart is fundamentally classified into 2 types as myocardial ischemia and non-ischemia. Several reports showed the clinical relevance of assessing of myocardial ischemia in consideration of indication of revascularization for the favorable prognosis in patients with ischemic heart disease using myocardial perfusion single-photon emission computed tomography (SPECT) imaging [5] or using a coronary pressure wire [6, 7] .
Non ischemic pathogenesis of the failing heart is varied and complex, such as genetically metabolic or protein production disorder, pressure or volume overload caused by hypertension or vulvular disease, microvascular dysfunction, drug-induced setting and are recommended modalities in the guidelines [14] . Fatty acid or glucose is utilized as the energy substrate of oxidative regeneration of adenosine triphosphate (ATP) in the mitochondria, and the mitochondrial function is visualized with 99m Tc-sestamibi [15, 16] , as described in detail later. Moreover, intracellular calcium handling, that needs an amount of ATPs in several processes, induces myocardial contraction and relaxation by the sliding of actin-myosin filament. Beta adrenal-stimulus by sympathetic nerve in the myocardium also regulates the intracellular calcium handling, and the myocardial sympathetic nerve function is imaged with 123 I-metaiodobenzil-guanidine ( 123 I-MIBG). In addition, the inflammation observed in cardiac sarcoidosis [17] or myocarditis could be identified with 18 F-FDG-PET, and the images of myocardial fibrosis [18] or amyloid are also investigated. Also, intramyocardial microvascular dysfunction could be seen in patients with hypertrophic cardiomyopathy (HCM) [19, 20] [39, 40] in patients with heart failure due to various pathogenesis, such as cardiomyopathy or ischemic heart disease. Recently, the standardization of the parameters, heart to mediastinum ration (H/M) or washout rate, became possible by the correction of the difference of a collimatorscinticamera system using the calibration phantom [41, 42] . Thus, a multi-center study named ADMIRE-HF trial was conducted [43] , and meta analysis of Japanese single cohort was also performed [44] . On the other hand, reduced myocardial functional reserve during a trial pacing tachycardia or during dobutamine stress test is reportedly caused by the impairment of intracellular calcium handling, especially of SERCA2 or phospholamban [46] [47] [48] in the failing heart; and that is related to the poor prognosis [4, 49] . However, the relationship between calcium handling and findings of non-invasive imaging has not yet been investigated. We therefore investigated the relationship between parameters of myocardial 123 I-MIBG SPECT, myocardial functional reserve during atrial pacing stress or dobutamine stress, and mRNA gene expression of the protein related to calcium handling or beta-adrenal signaling in myocardial tissue in patients with idiopathic dilated cardiomyopathy (DCM) and HCM.
At first, we reported that patients with reduced delayed H/M showed an impairment in myocardial functional reserve with reduced mRNA expressions of sarcoplasmic reticulum calcium ATPase (SERCA2a) and phospholamban during atrial pacing tachycardia in 24 DCM patients [50] .
Next, we demonstrated significant correlations between washout rate or delayed H/M and myocardial functional reserve in DCM patients ( Figure 1 ) [51, 52] . Moreover, these parameters also associated with mRNA expressions of the proteins related to calcium handling or beta-adrenal signaling.
We also demonstrated that 123 I-MIBG parameters are associated with impaired myocardial functional reserve during atrial pacing tachycardia in 30 HCM patients [53] .
Mitochondrial Functional Imaging with 99m

Tc-Sestamibi
Myocardial mitochondria produce ATP as a myocardial energy source [54] . Intra-mitochondria have a strong negative membrane potential of -161±7 mV [55] . When cardiomyocytes are impaired by myocardial ischemia or other causes, the mitochondrial membrane potential is increasing [56] . 99m Tc-sestamibi, which is generally used as the tracer of myocardial perfusion imaging, is a mono-positive ion, and usually retained within the mitochondria by the strong negative membrane potential [57] . However, when mitochondria is impaired, the mitochondrial membrane potential increases, and subsequently 99m Tc-sestamibi is washed out [58] .
It is reported that mitochondria in large clusters varied in size and shape with few myofibrils in cytoplasm of extracted myocardial tissue of DCM patients [59] . Also, it is reported that mitochondrial damages were seen in several other heart diseases [54] .
In experimental studies, increased washout of 99m Tc-sestamibi was demonstrated in the pathological situation with mitochondrial injury as a model of myocardial ischemia and reperfusion [60] , of hypertensive heart failure [61] , and of pharmacological mitochondrial injury [62] .
And also, several clinical investigations have demonstrated that washout of 99m Tc-sestamibi is observed in patients with myocardial infarction after reperfusion [63, 64] , those with severe ischemia with triple vessel disease [65] , those with non-ischemic cardiomyopathy [15, 66, 67] , those with mitochondrial cardiomyopathy [68] , and those with post-chemotherapy cardiomyopathy [69] .
We similarly investigated the relationship between the washout of 99m Tc-sestamibi and the myocardial functional reserve of force frequency relation in patients with non-ischemic cardiomyopathy.
We demonstrated that washout rate of 99m Tc-seatamibi was associated with myocardial functional reserve during dobutamine stress, mitochondrial morphological, and functional abnormalities in 20 DCM patients (Figure 2 ) [70] . DCM patients with increased washout of 99m Tc-sestamibi showed reduced mRNA expressions of the proteins related to the mitochondrial electron transport chain. Significant correlations were observed between washout rate of 99m Tcsestamibi and mitochondrial morphological abnormalities, as shown in the abnormal mitochondrial shape and size, degeneration of the cristae formation, and the presence of glycogen positive area which represent impairments in glucose utilization.
In 30 HCM patients, increased washout of 99m Tc-sestamibi was also related with impaired force frequency relations during atrial pacing stress, and with mitochondrial functional damage of the protein related to electron transport, morphological abnormality of mitochondria as shown in disorganization or variation in size and increased number of mitochondria ( Figure 3 ) [71, 72] .
Clinical Significance of Each Imaging in the Failing Heart
Myocardial mitochondria produce about 30 kg/day of ATP to maintain myocardial function [54] . Myocardial contraction and relaxation are caused by sliding of actin and myosin filaments with intracellular calcium handling, which needs ATPs in several processes ( Figure 4 ) [73] . When myocardial mitochondria are impaired, these processes do not work well, resulting in cardiac functional deterioration [74] .
Beta-adrenal stimulus initiates and regulates the calcium handling process. The down-regulation of beta receptors in the failing myocardium impairs phosphorylation of phospholamban, reducing an influx of calcium into sarcoplasmic reticulum, eventually resulting in an impairment of cardiac function [75] . On the other hand, overphosphorylation of ryanosine receptor of sarcoplasmic reticulum causes intracellular calcium overload, and also accelerates the reduction of cardiac function [76, 77] . Carvedilol protects of SERCA2a [78] , or metoprolol up-regulates the number of beta receptor [79] , resulting in the amelioration of calcium handling, and subsequently restoring the cardiac function.
Consequently, it is clinically very important to figure out the perspective of the pathogenesis the failing heart, not only with regard to sympathetic nervous system or mitochondrial function but also calcium handling or beta-adrenal signaling using myocardial 99m Tcsestamibi or 123 I-MIBG imaging.
Conclusion
The myocardial imaging with 99m Tc-sestamibi and 123 I-MIBG could visualize myocardial mitochondrial or sympathetic nerve function that is closely related to myocardial work in the molecular level. These radionuclide imaging contribute to make for a profound understanding of the essential mechanism of pathogenesis in the failing myocardium.
The nuclear imaging with several tracers could image several component related to the cardiac work, such as myocardial metabolism of glucose and fatty acid with oxygen, ATP production in mitochondria, sympathetic nerve function, in inflammation, or fibrosis. Assessments of the pathogenesis the failing myocardium using these tracers provide not only appropriate patient care and treatment but also prediction of prognosis in heart failure patients. 
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